Davita Healthcare Partners Inc (DVA) 76.08 $DVA DaVita

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Davita Healthcare Partners Inc (DVA) 76.08 $DVA

DaVita Announces Intent to Enter into Transaction with Inspira Health Network to Provide Dialysis Services
PR Newswire - Wed Jun 08, 7:24AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA), today announced its intent to enter into a joint venture acquisition with Inspira Health Network that will bring DaVita's industry-leading quality patient care to Southern New Jersey. The proposed joint venture would transfer majority ownership of three Inspira dialysis centers located in Vineland, Millville and Bridgeton to DaVita and create opportunities to grow dialysis services throughout the communities which Inspira currently serves.
DVA: 76.08 (-1.13)

DaVita Kidney Care Releases Free Kidney-Friendly Cookbook
PR Newswire - Tue May 24, 5:13AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services committed to improving the quality of life for those diagnosed with chronic kidney disease (CKD), today announced the launch of its 2016 summer cookbook, a tasty collection of grilling and picnic recipes to encourage outdoor fun with friends and family.
DVA: 76.08 (-1.13)

DaVita to Expand in Orlando with Family Health Care Buyout
Zacks Equity Research - Zacks Investment Research - Mon May 23, 3:07PM CDT
DaVita Healthcare Partners (DVA) has entered into a definitive agreement to acquire Family Health Care of Central Florida to expand its presence in Orlando metro area.
PMC: 26.43 (-0.66), AFAM: 42.11 (-0.81), DVA: 76.08 (-1.13), HLS: 40.54 (-1.02)

DaVita, Northwell Health Announce Joint Venture to Deliver Full Suite of Kidney Care Services
PR Newswire - Thu May 19, 10:41AM CDT
Northwell Health (formerly North Shore-LIJ Health System) and DaVita Kidney Care, a division of DaVita HealthCare Partners (NYSE: DVA) today announced a new joint venture to serve thousands of patients in Queens and Long Island with integrated kidney care.
DVA: 76.08 (-1.13)

DaVita Announces Agreement to Acquire a Prominent Medical Group in Orlando Area
PR Newswire - Thu May 19, 8:16AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group in the United States and leading global provider of kidney care services, announced that it entered into a definitive agreement to acquire Family Health Care of Central Florida, a highly reputable primary care group serving the Orlando metro area for more than 30 years. The transaction is expected to close in the near future. Financial terms were not disclosed.
DVA: 76.08 (-1.13)

DaVita HealthCare Partners Certified as Freedom-Centered Workplace by WorldBlu
PR Newswire - Thu May 12, 5:13AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that the company has been certified as a "Freedom-Centered Workplace" by WorldBlu. This is the ninth consecutive year the company has been recognized on the list, formerly known as "most democratic" workplaces.
DVA: 76.08 (-1.13)

DaVita Appoints President for Kidney Care Business in Asia Pacific
PR Newswire - Tue May 10, 10:00AM CDT
DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a global provider of kidney care services, today announced that Rehan Khan will serve as president of the company's kidney care business in Asia Pacific.
DVA: 76.08 (-1.13)

Look for Shares of DaVita to Potentially Pullback after Yesterday's 3.50% Rise
Comtex SmarTrend(R) - Thu May 05, 2:09PM CDT
DaVita (NYSEVA) traded in a range yesterday that spanned from a low of $74.19 to a high of $75.95. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $74.53 on volume of 826,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DVA: 76.08 (-1.13)

DaVita Rises 3.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu May 05, 2:08PM CDT
DaVita (NYSEVA) traded in a range yesterday that spanned from a low of $74.19 to a high of $75.95. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $74.53 on volume of 826,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DVA: 76.08 (-1.13)

DaVita HealthCare (DVA) Q1 Earnings Beat as Revenues Rise
Zacks Equity Research - Zacks Investment Research - Thu May 05, 10:39AM CDT
DaVita HealthCare Partners Inc. (DVA) reported first-quarter 2016 adjusted operating earnings of 92 cents per share that surpassed the Zacks Consensus Estimate of 87 cents by 5.75%. Earnings increased 7% year on year.
ANTM: 131.52 (-2.23), DVA: 76.08 (-1.13), MOH: 50.73 (-1.14), HUM: 186.76 (-1.59)

DaVita, Khazanah and Mitsui to Create Joint Venture to Expand Kidney Care Services in Asia Pacific
PR Newswire - Wed May 04, 3:01PM CDT
DaVita Kidney Care, a division of DaVita (NYSE: DVA) and a leading provider of kidney care services in the United States, today announced the signing of a definitive agreement that, subject to certain closing conditions, will create a long-term joint venture. The joint venture with Khazanah Nasional Berhad, the strategic investment fund of the Government of Malaysia, and Mitsui & Co., LTD., one of the most diversified and comprehensive trading, investment and service companies in the world, is intended to support the growth of DaVita Kidney Care operations in the Asia-Pacific region.
DVA: 76.08 (-1.13)

Watch for Healthcare Stocks in Q1 Earnings: DVA, HCA, HUM
Zacks Equity Research - Zacks Investment Research - Mon May 02, 8:19AM CDT
A sneak peek into three major healthcare companies that are lined up to report earnings this week.
HCA: 79.55 (-1.48), DVA: 76.08 (-1.13), HUM: 186.76 (-1.59)

DaVita (DVA) Likely to Top Q1 Earnings: Stock to Gain?
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:08AM CDT
We expect DaVita HealthCare Partners Inc. (DVA) to beat expectations when it reports first-quarter 2016 results on May 4, after the market closes.
ACET: 22.52 (-0.15), BDX: 169.29 (-0.94), DVA: 76.08 (-1.13), BIND: 0.40 (-0.01)

DaVita Teammates Honored for Exemplifying Core Values
PR Newswire - Wed Apr 27, 5:24AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced that during its annual Villagewide meeting, April 13-16, the company recognized teammates for exemplifying its core values.
DVA: 76.08 (-1.13)

DaVita HealthCare Partners Inc. Schedules 2016 Capital Markets Day
PR Newswire - Tue Apr 26, 5:17PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its Capital Markets Day in New York City on Wednesday, May 18, 2016, from 8:30 a.m. to noon Eastern Time.
DVA: 76.08 (-1.13)

DaVita HealthCare Partners Inc. Schedules 1st Quarter 2016 Investor Conference Call
PR Newswire - Tue Apr 26, 5:14PM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA) announced today that it will hold its quarterly conference call to discuss first quarter results on Wednesday, May 4, 2016, at 5:00 p.m. Eastern Time.
DVA: 76.08 (-1.13)

DaVita Reports on 2015 Corporate Social Responsibility and Innovation
PR Newswire - Thu Apr 21, 5:13AM CDT
DaVita HealthCare Partners Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced the release of its 2015 Community Care report, which highlights key clinical, operational and corporate social responsibility (CSR) achievements in the past year.
DVA: 76.08 (-1.13)

UnitedHealth (UNH) May Beat Q1 Earnings: Will Stock Gain?
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 1:55PM CDT
We expect UnitedHealth Group Inc. (UNH) to beat expectations when it reports first-quarter results on Apr 19, before market opens.
DVA: 76.08 (-1.13), UNH: 139.24 (-1.44), ABBV: 61.00 (+0.25), HUM: 186.76 (-1.59)

DaVita to Acquire Mountain View, Expand Footprint in Colorado
Zacks Equity Research - Zacks Investment Research - Mon Apr 11, 1:35PM CDT
DaVita HealthCare Partners Inc. (DVA) intends to acquire Mountain View Medical Group to enhance its kidney care services and extend footprint in Colorado Springs.
ABUS: 3.60 (-0.33), AFAM: 42.11 (-0.81), DVA: 76.08 (-1.13), AMED: 51.80 (-1.00)

Mountain View Medical Group to Join DaVita HealthCare Partners
PR Newswire - Fri Apr 08, 9:03AM CDT
DaVita HealthCare Partners (NYSE: DVA), a leading independent medical group in America and leading global provider of kidney care services, today announced the company's intent to acquire Mountain View Medical Group, a leading independent physician group in Colorado Springs. Under the proposal, Mountain View Medical Group would join the company's HealthCare Partners division. Financial terms were not disclosed.
DVA: 76.08 (-1.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 115

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 87

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Rutter Mills Expands Turkey Giveaway to Two Cities

Updated Category News Views 101

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 194

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 77

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 130

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 159

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 154

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 180

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading

Top 5 Most Recently Viewed Articles

GigaCloud Technology's Continued Success on Forbes List 2026

Updated Category News Views 308

GigaCloud Technology Inc Shines on Forbes’ Small-Cap Companies List GigaCloud Technology Inc (Nasdaq: GCT) has once again earned a distinguished spot on Forbes’ notable list of America’s Most Successful Small-Cap Companies. This recognition reflects the Company’s ongoing commitment to innovation within its sector, marking an important milestone as they’ve been...

Continue Reading
Harvia Plc: Key Insights on the Upcoming AGM and Governance

Updated Category News Views 254

Invitation to Harvia Plc's Annual General Meeting Harvia Plc has extended an invitation to its shareholders for the upcoming Annual General Meeting. This event is crucial for stakeholders as it will shape the direction of the company for the coming fiscal year. Highlights of the Meeting Agenda The Annual General Meeting (AGM) will encompass various significant topics...

Continue Reading
Rokmaster's Closing of Second Funding Tranche Strengthens Future Exploration

Updated Category News Views 206

Rokmaster Resources Corp. Completes Final Funding Round Rokmaster Resources Corp. (TSXV: RKR) (OTCQB: RKMSF) is delighted to announce that it has successfully completed the final tranche of its flow-through financing. This financing initiative is crucial for the company as it enhances its capability to explore and develop its mining properties effectively. Details of the...

Continue Reading
Industrial Logistics Properties Trust Shares Q3 2024 Financials

Updated Category News Views 92

Industrial Logistics Properties Trust Shares Q3 2024 Financials Industrial Logistics Properties Trust (NASDAQ: ILPT) has recently announced its financial performance for the quarter ending September 30, 2024. This quarterly report sheds light on the company's operational and financial health, vital for current and prospective investors. Key Highlights and Financial...

Continue Reading
Cocrystal Pharma's CDI-988 Targets Viral Infections with Promise

Updated Category News Views 133

Cocrystal Pharma, Inc. is making waves in the biotech ocean with its oral pan-viral protease inhibitor, CDI-988. This bad boy recently entered the multiple-ascending dose (MAD) phase of a Phase 1 clinical study, a crucial milestone for evaluating both efficacy and safety as it aims to knock out viral infections broadly. With topline results expected to drop in late 2024...

Continue Reading